What antibiotics are safe for a breastfeeding mother, and what are the preferred alternatives if she has a severe penicillin allergy?

Antibiotics Safe for Breastfeeding Mothers

β-lactam antibiotics—including penicillins, ampicillin, cephalosporins (such as cefazolin and ceftriaxone), and carbapenems—are the safest first-line choices for breastfeeding mothers, with tetracyclines and fluoroquinolones avoided due to potential developmental impacts on the infant. 1

First-Line Safe Antibiotics During Lactation

β-Lactam Antibiotics (Preferred)

• Penicillins and ampicillin are commonly used and considered safe overall during breastfeeding 1
• Cephalosporins (including cefazolin, ceftriaxone, and third- or fourth-generation agents) are safe and provide broad gram-positive, gram-negative, and anaerobic coverage 1
• Carbapenems are safe options, though they have limited coverage for Enterococcus species 1
• These agents achieve limited excretion into breast milk, have poor oral absorption by the infant, and minimal effect on the newborn 1

Other Safe Options

• Metronidazole is safe for anaerobic coverage 1
• Clindamycin is considered relatively safe despite heterogeneity in data, with minimal quantities ingested through breast milk 2
• Vancomycin appears relatively safe in the minimal quantities nursing infants ingest 2

Antibiotics to Avoid During Breastfeeding

• Tetracyclines (tetracycline, doxycycline, minocycline) should be avoided due to potential developmental impacts on the baby 1
• Fluoroquinolones are generally avoided because of potential developmental impacts 1

---

Management of Severe Penicillin Allergy in Breastfeeding Mothers

Defining Severe Penicillin Allergy

Severe penicillin allergy includes a history of anaphylaxis, angioedema, respiratory distress, or urticaria following penicillin or cephalosporin administration. 3

Treatment Algorithm for Severe Penicillin Allergy

Step 1: Assess Cross-Reactivity Risk

• For severe penicillin allergy (anaphylaxis history): Third- or fourth-generation cephalosporins with low R1 side chain similarity (such as ceftriaxone) pose minimal cross-reactivity risk and can be administered without prior testing 1
• Carbapenems may be given without testing or additional precautions, irrespective of whether the penicillin reaction was anaphylactic 1
• Aztreonam (a monobactam) can be administered without prior testing, except in patients allergic to ceftazidime due to identical R1 side chains 1
• Approximately 10% of persons with penicillin allergy have immediate hypersensitivity reactions to cephalosporins 1

Step 2: Alternative Antibiotics Based on Susceptibility Testing

If β-lactams must be avoided entirely:

• Obtain susceptibility testing for clindamycin and erythromycin on any bacterial isolate (particularly GBS) from penicillin-allergic patients at high risk for anaphylaxis 4, 5
• If susceptible to both clindamycin and erythromycin: Use clindamycin 900 mg IV every 8 hours 4, 5, 3
• If resistant to either agent or susceptibility unknown: Use vancomycin 1 g IV every 12 hours 4, 5, 3
• Perform D-zone testing on isolates that are erythromycin-resistant but clindamycin-susceptible to detect inducible clindamycin resistance 4, 5

Step 3: Lactation Safety of Alternatives

• Clindamycin is relatively safe during breastfeeding, with minimal quantities ingested through breast milk 2
• Vancomycin appears relatively safe in the minimal quantities nursing infants ingest through breast milk 2
• Both agents are acceptable for use in lactating women when β-lactams cannot be used 2, 6

Critical Pitfalls to Avoid

• Do not assume all cephalosporins are contraindicated in penicillin allergy—third- and fourth-generation agents have minimal cross-reactivity with penicillin in anaphylaxis history 1
• Always obtain susceptibility testing when treating infections in penicillin-allergic patients, as clindamycin resistance ranges from 3–15% among bacterial isolates 3
• Avoid erythromycin as it is no longer recommended due to increasing resistance and unreliable tissue penetration 1, 3
• Reserve vancomycin for cases where no other options exist due to concerns about promoting antimicrobial resistance 5

Key Resource

• LactMed (National Institutes of Health) is a peer-reviewed database providing insights into potential adverse effects of drugs on nursing infants and should be consulted when selecting antimicrobials during lactation 1